scispace - formally typeset
Journal ArticleDOI

Antisense oligonucleotides: a new therapeutic principle

Eugen Uhlmann, +1 more
- 01 Jun 1990 - 
- Vol. 90, Iss: 4, pp 543-584
Reads0
Chats0
About
This article is published in Chemical Reviews.The article was published on 1990-06-01. It has received 2224 citations till now. The article focuses on the topics: Antisense RNA.

read more

Citations
More filters
Patent

Transgenic non-human animals capable of producing heterologous antibodies

TL;DR: In this paper, a transgenic non-human animals capable of producing heterologous antibodies and methods for producing human sequence antibodies which bind to human antigens with substantial affinity are described.
Patent

Transgenic non-human animals for producing heterologous antibodies

TL;DR: In this paper, a transgenes containing sequences of unrearranged heterologous human immunoglobulin heavy chains are introduced into a non-human animal, thereby forming a transgenic animal capable of functionally rearranging transgenio-globulin sequences and producing a repertoire of antibodies.
Patent

Transgenic non-human animals capable of producing heterologous antibodies of various isotypes

TL;DR: In this article, a transgenes containing sequences of unrearranged heterologous human immunoglobulin heavy chains are introduced into a non-human animal, thereby forming a transgenic animal capable of functionally rearranging transgenio-globulin sequences and producing a repertoire of antibodies.
Journal ArticleDOI

PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules

TL;DR: It is reported here that PNA containing all four natural nucleobases hybridizes to complementary oligonucleotides obeying the Watson–Crick base-pairing rules, and thus is a true DNA mimic in terms of base- Pair recognition.
Journal ArticleDOI

Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics

TL;DR: Aptamers are different from antibodies, yet they mimic properties of antibodies in a variety of diagnostic formats, and may play a key role either in conjunction with, or in place of, antibodies in the form of aptamer-based diagnostic products in the market.
Related Papers (5)